Literature DB >> 11177735

Toxoplasmosis.

Joseph D. Schwartzman1.   

Abstract

Recent advances in understanding toxoplasmosis have been made in the areas of the basic biology of the parasite and the host-parasite interaction, especially the cellular immune response. There is new insight into the biology of the cyst stage that is responsible for meat-associated transmission of infection and for the reactivation of disease in chronically infected humans. Fewer recent advances have been made in clinical diagnosis and treatment of toxoplasmosis. The fascinating revelation that Toxoplasma gondii contains an organelle--now known as the apicoplast--that derives from an algal endosymbiont, has opened many avenues of basic investigation. An understanding of the fundamental biology of T. gondii promises future progress in prevention or treatment of toxoplasmosis.

Entities:  

Year:  2001        PMID: 11177735     DOI: 10.1007/s11908-001-0063-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  34 in total

1.  Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation.

Authors:  Y W Zhang; K Kim; Y F Ma; M Wittner; H B Tanowitz; L M Weiss
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

2.  Serine protease inhibitors block invasion of host cells by Toxoplasma gondii.

Authors:  V Conseil; M Soête; J F Dubremetz
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 3.  Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

Authors:  J P Dubey; D S Lindsay; C A Speer
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Induction of an acrosomal process in Toxoplasma gondii: visualization of actin filaments in a protozoan parasite.

Authors:  M K Shaw; L G Tilney
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 5.  Advances in the life cycle of Toxoplasma gondii.

Authors:  J P Dubey
Journal:  Int J Parasitol       Date:  1998-07       Impact factor: 3.981

6.  Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.

Authors:  W Foulon; I Villena; B Stray-Pedersen; A Decoster; M Lappalainen; J M Pinon; P A Jenum; K Hedman; A Naessens
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

7.  Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak.

Authors:  A J Burnett; S G Shortt; J Isaac-Renton; A King; D Werker; W R Bowie
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

8.  Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii.

Authors:  I A Khan; T Matsuura; L H Kasper
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

Review 9.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

10.  Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G S Yap; A Sher
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

View more
  2 in total

1.  Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondii.

Authors:  Rui Chen; Shao-Hong Lu; Qun-Bo Tong; Di Lou; Dong-Yan Shi; Bing-Bing Jia; Guo-Ping Huang; Jin-Fu Wang
Journal:  J Zhejiang Univ Sci B       Date:  2009-07       Impact factor: 3.066

2.  Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB/c mice.

Authors:  Fatemeh Ghaffarifar; Mohammad Jafarimodrek; Hossein Vazini; Zohreh Sharifi; Abdolhossein Dalimi; Mohammad Saaid Dayer
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.